Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Dev Med Child Neurol. 2017 Feb 6;59(6):605–611. doi: 10.1111/dmcn.13398

Table I.

Frequency distribution (n, %) of mutation type, age group, walking ability, and comorbidity status for individuals in the Australian Rett Syndrome Database in 2012

Able to walk independently or with assistance Unable to walk
n=94)
StepWatch data available
(n=64)
No StepWatch data available
(n=93)
Common mutation C-terminal deletion 9 (14) 9 (10) 8 (9)
Early truncating 1 (2) 5 (5) 11 (12)
Large deletion 4 (6) 2 (2) 6 (6)
p.Arg106Trp 4 (6) 3 (3) 3 (3)
p.Arg133Cys 7 (11) 10 (11) 1 (1)
p.Arg168* 6 (9) 4 (4) 12 (13)
p.Arg255* 8 (9) 7 (7)
p.Arg270* 2 (3) 5 (5) 7 (7)
p.Arg294* 6 (9) 10 (11) 2 (2)
p.Arg306Cys 6 (9) 4 (4)
p.Thr158Met 5 (8) 7 (8) 9 (10)
Other 7 (11) 10 (11) 9 (10)
Negative 7 (11) 16 (17) 19 (20)
Age (y) <13 25 (39) 21 (23) 33 (35)
13–18 11 (17) 21 (23) 23 (25)
≥19 28 (44) 51 (55) 38 (40)
Walking ability Unable to walk 94 (100)
Assisted 15 (23) 27 (29)
Independent 49 (77) 66 (71)
Scoliosisa Diagnosed 32 (50) 59 (63) 80 (86)
Frequency of seizuresb Never or none in the last 2 years 33 (52) 33 (49) 28 (37)
Less than monthly or monthly 17 (27) 19 (28) 21 (28)
Weekly or daily 14 (22) 15 (22) 26 (35)
a

Scoliosis data for 93 individuals who could walk independently or with assistance who did not provide StepWatch data, and for 93 individuals who were unable to walk.

b

Data for 67 individuals who could walk independently or with assistance who did not provide StepWatch data, and for 75 individuals who were unable to walk.